IRIS
MENZO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.958
EU - Europa 1.904
AS - Asia 563
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
SA - Sud America 2
Totale 6.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.953
UA - Ucraina 461
IT - Italia 316
IE - Irlanda 272
DE - Germania 222
SG - Singapore 203
SE - Svezia 194
DK - Danimarca 171
CN - Cina 157
FI - Finlandia 103
TR - Turchia 97
KR - Corea 91
GB - Regno Unito 73
FR - Francia 65
CI - Costa d'Avorio 59
MA - Marocco 17
BE - Belgio 16
IN - India 13
CA - Canada 5
EU - Europa 5
A1 - Anonimo 2
CZ - Repubblica Ceca 2
JP - Giappone 2
MK - Macedonia 2
PL - Polonia 2
PY - Paraguay 2
RO - Romania 2
AO - Angola 1
AU - Australia 1
HR - Croazia 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 6.513
Salva come PNG Salva come JPEG
Città #
Jacksonville 479
Chandler 441
Fairfield 376
Des Moines 301
Dublin 272
Boardman 249
Ashburn 235
Wilmington 189
Woodbridge 165
Houston 153
Seattle 139
Ann Arbor 119
New York 116
Lawrence 107
Princeton 107
San Mateo 107
Cambridge 100
Redmond 70
Singapore 66
Abidjan 59
San Diego 52
Civitanova Marche 38
Centro 35
London 23
Ancona 20
Turin 19
Beijing 18
Brussels 16
Marche 16
Helsinki 14
Wuhan 14
Guangzhou 12
Washington 12
Appignano 11
Shanghai 11
Los Angeles 10
Norwalk 10
Hanover 9
Chicago 7
Cingoli 7
Falls Church 7
Pune 7
Rome 7
Milan 6
Monte San Pietrangeli 6
Bari 5
Cagliari 4
Fano 4
Jinhua 4
Kilburn 4
Ottawa 4
Chiswick 3
Delhi 3
Fayetteville 3
Jiaxing 3
Pesaro 3
Senigallia 3
Tappahannock 3
Tolentino 3
Wuxi 3
Arco 2
Asunción 2
Bologna 2
Casalecchio di Reno 2
Caserta 2
Cava De' Tirreni 2
Chengdu 2
Dallas 2
Dugenta 2
Hounslow 2
Köseköy 2
Macerata 2
New Bedfont 2
Porto 2
Quanzhou 2
Seoul 2
Shenzhen 2
Southend 2
Stillwater 2
Torre Annunziata 2
Weihai 2
Yiwu 2
Acton 1
Andover 1
Angri 1
Auburn Hills 1
Auckland 1
Belgrade 1
Belvedere Spinello 1
Birmingham 1
Boston 1
Budapest 1
Cantu 1
Casale Monferrato 1
Castelfranco Emilia 1
Cologno Monzese 1
Copenhagen 1
Corinaldo 1
Corridonia 1
Denver 1
Totale 4.351
Salva come PNG Salva come JPEG
Nome #
Antimicrobial Resistance: A Challenge for the Future 159
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 109
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 109
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 102
Hepatitis E in a region of Italy: An emerging autochthonous infection? 100
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 99
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 98
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 98
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 96
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 89
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 88
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 86
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 86
null 86
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 85
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 84
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 83
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 80
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 80
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 79
Tocilizumab in COVID-19 interstitial pneumonia 79
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 77
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 76
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 76
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 75
Quantitative molecular methods in virology. 74
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 74
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 74
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 72
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 72
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 71
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 69
Quantitative PCR and RT-PCR in virology. 68
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 68
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 67
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 66
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 65
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 65
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 63
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 63
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 63
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 63
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 62
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 60
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 59
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 59
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 59
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 59
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 58
Human papillomavirus infections: new perspectives for prevention and treatment. 57
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 57
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 56
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 55
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 55
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 55
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 55
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 55
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 54
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 54
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 53
null 53
42. Adenoviridae 52
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 52
Clearance of HIV-1 viraemia after seroconversion. 52
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 51
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis). 50
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 50
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 50
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 49
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients. 48
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 48
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 48
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 48
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 48
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 47
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 46
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 46
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 46
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 46
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. 45
Direct detection of HBV preC mutants in heterogeneous viral populations by a modified DNA sequencing method. 45
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 44
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 44
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 44
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. 44
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 43
Quantitation of hepatitis C virus genome molecules in plasma samples. 43
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 43
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 42
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 42
Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. 42
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 41
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds 41
Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients. 41
The introduction of the fusion inhibitors in the HAART-regimens. 39
Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. 38
No evidence of association between Borrelia Burgdorferi and primary cutaneous B-cell lymphomas in Marche Region, in Italy. 38
Insulin-like growth factor 1 (IGF-1) expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab-irinotecan. 38
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining 38
Infezione da Borrelia Burgdorferi e linfomi cutanei a cellule B nella regione marche 36
Totale 6.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 0 5 102 3 110 8 98 22 21 132
2020/20211.504 81 196 251 24 147 86 134 110 139 123 150 63
2021/2022882 83 211 13 24 10 53 56 58 67 58 68 181
2022/20231.545 136 116 124 113 117 393 10 72 330 6 99 29
2023/2024824 134 16 50 118 167 151 8 40 13 15 17 95
2024/2025453 214 153 84 2 0 0 0 0 0 0 0 0
Totale 6.615